{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:04:29Z","timestamp":1782601469691,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":1313,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jtcvs.2012.06.049","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T16:32:06Z","timestamp":1343233926000},"page":"1352-1359.e1","source":"Crossref","is-referenced-by-count":18,"title":["Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"144","author":[{"given":"Shau-Hsuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-I","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chueh-Chuan","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2012.06.049_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00000658-200109000-00010","article-title":"Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world","volume":"234","author":"Siewert","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jtcvs.2011.01.053","article-title":"Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma","volume":"141","author":"Lee","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib3","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib4","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-009-0862-1","article-title":"Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer","volume":"17","author":"Meredith","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jtcvs.2009.07.069","article-title":"Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?","volume":"138","author":"Meguid","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib7","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","article-title":"Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival","volume":"23","author":"Berger","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drup.2008.03.001","article-title":"Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment","volume":"11","author":"Jiang","year":"2008","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib10","doi-asserted-by":"crossref","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. Esophagus and esophagogastric junction. In: AJCC Cancer Satging Manual. 7th ed. New York: Springer; 2010:103-11.","DOI":"10.1007\/978-0-387-88441-7_10"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib11","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1158\/1078-0432.CCR-07-4719","article-title":"Temsirolimus, an inhibitor of mammalian target of rapamycin","volume":"14","author":"Rini","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib12","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1245\/s10434-010-1040-1","article-title":"Phosphorylated mTOR expression is associated with poor prognosis for patients\u00a0with esophageal squamous cell carcinoma","volume":"17","author":"Hirashima","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.23996","article-title":"Critical and diverse involvement of Akt\/mammalian target of rapamycin signaling in human lung carcinomas","volume":"115","author":"Dobashi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/modpathol.2009.104","article-title":"EGFR-dependent and independent activation of Akt\/mTOR cascade in bone and soft tissue tumors","volume":"22","author":"Dobashi","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib15","first-page":"163","article-title":"(-)-Epigallocatechin-3-gallate enhances anti-tumor effect of cytosine arabinoside on HL-60 cells","volume":"24","author":"Xu","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-007-9746-x","article-title":"Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables","volume":"110","author":"Noh","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib17","first-page":"5239","article-title":"The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway","volume":"58","author":"Moore","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jtcvs.2006.05.015","article-title":"Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy","volume":"132","author":"Reynolds","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1634\/theoncologist.12-12-1395","article-title":"Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas","volume":"12","author":"Lefranc","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2004.12.040","article-title":"The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation","volume":"120","author":"Beuvink","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib22","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib23","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"Mondesire","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib24","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1158\/1078-0432.CCR-11-0190","article-title":"Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun","volume":"17","author":"Itamochi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s11605-009-0948-x","article-title":"Effective treatment of advanced colorectal cancer by rapamycin and 5-FU\/oxaliplatin monitored by TIMP-1","volume":"13","author":"Wagner","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jtcvs.2012.06.049_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2009.09.015","article-title":"mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice","volume":"290","author":"Hou","year":"2010","journal-title":"Cancer Lett"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522312007283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522312007283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:40:24Z","timestamp":1562002824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522312007283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0022522312007283"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2012.06.049","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}